ELOCP8

Across TCGA pan-cancer cohorts, ELOCP8 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated ELOCP8 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher ELOCP8 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELOCP8 expression acts as an unfavorable survival marker.

KICH are the cancer types where ELOCP8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

ELOCP8–KICH (DFS)

Open the KICH breakdown →